Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct-acting antivirals.

The LS value at baseline is useful for predicting HCC occurrence. Thus, even if SVR is achieved, patients with higher LS at baseline must be followed carefully for HCC occurrence.